Accipiter Biosciences

Accipiter Biosciences designs and develops de novo protein therapies using advanced computational methods to treat complex diseases such as cancer and autoimmune disorders. The company's platform creates multifunctional proteins that can activate multiple cellular pathways simultaneously, aiming to improve therapeutic outcomes over traditional combination therapies. They generate value through internal drug development programs and strategic partnerships with pharmaceutical giants.